bioSyntagma Company
bioSyntagma develops molecular fingerprint for diagnosing and discovering disease.
Industry:
Aging Biomarkers
Estimated Revenue:
$1M to $10M
Technology:
['BioTech & HealthTech', 'Education, Research & SocialTech']
Headquarters:
Phoenix, Arizona, United States
Total Funding:
1382086
Last Funding Date:
2018-03-19
Last Funding Type:
Grant
Employee Number:
1-10
Investors Number:
2
Founded Date:
2015-04-02